PLD2 and mTORC2 are required to convert increases in membrane tension to decreases in actin network assembly. by Alba Diz-Muñoz (236517)

“…Boxes in all box plots (B) extend from the 25th to 75th percentiles, with a line at the median. Whiskers extend to ×1.5 IQR (interquartile range) or the max/min data points if they fall within ×1.5 IQR.…”

Co-contraction and the grasp force decreased with the block number. by Atsushi Takagi (3363320)

Increased isolated activity via Piezo1 decreases DRG cell divisions and reduces response to cold stimulus. by Jacob P. Brandt (11725253)

Cause of decreased implantation sites were not due to “flush out” of embryos, but due to abnormal “on time” and “on site” implantation. by Shan Lu (50076)

Mcl-1 protein expression is decreased by internal dsRNA and its modulation regulates beta cell apoptosis. by Maikel L. Colli (179059)

Microbiocidal activity and limited bacteria-cell contact does not provide for decreased phagocytic clearance of non-swimming bacteria. by Rustin R. Lovewell (205423)

Phlorizin reduced tissue ATP content in the heart, associated with decreased glucose uptake and glycolytic flux during IRI. by Yusuke Kashiwagi (762406)

Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils. by Jian Hao (160736)

“…C and D: blocking CD88 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. …”

Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

“…The receiver-operating-characteristic curve was used to define a cut-off point corresponding to the best area under the curve (AUC; [CI95%]) to detect arterial stenosis ≥50% as determined by the CTA.…”

A decrease of <i>MHCII</i>, <i>Dl4</i>, and <i>Ccl25</i> but an increase in <i>Il7</i> in the <i>Foxn1</i>^<i>lacZ</i> thymus. by Shiyun Xiao (75798)

Viability of <i>MRE11</i>, <i>mre11A470T</i>, <i>rap1-5</i>, <i>and mre11A470T rap1-5</i>. by In-Joon Baek (4423057)

“…<i>mre11A470T</i> and <i>mre11A470T rap1-5</i> cells had decreased viability only at 37°C. …”

Serotype-specific penicillin non-susceptibility during different PCV periods in Iceland, Romania, Spain and Belgium [68, 69, 76, 78, 84, 85]. by Heloisa Ricci Conesa (18291210)

Procedures of sampling and measurements. by Xuegang Mao (599968)

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Administration of anti-CD25 antibody decreases the early and late organ fungal burdens of resistant and susceptible mice. by Maíra Felonato (296591)

Data extraction grid. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

Inclusion criteria. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

“…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)